Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Well, there you go. If Natco has indeed had multiple analyst upgrades in the past week or so, that explains the recent movement in the share price and it's silly to speculate about an FDA leak concerning MYL's Copaxone ANDA.

Moreover, if there were really an FDA leak regarding MYL’s Copaxone ANDA, one would expect s sharp movement in MYL’s own share price, but there hasn’t been one.